SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-065902
Filing Date
2022-05-27
Accepted
2022-05-27 16:16:58
Documents
1
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2217184-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2217184-2_4seq1.xml 4 6059
  Complete submission text file 0001104659-22-065902.txt   7514
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 FIFTH AVENUE #8C NEW YORK NY 10021
Business Address
Gottesdiener Keith Michael (Reporting) CIK: 0001615856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 22977743